Na(+)/K(+)-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), identified for the first time in Wuhan, China, causes coronavirus disease 2019 (COVID-19), which moved from epidemic status to becoming a pandemic. Since its discovery in December 2019, there have been countless cases of mortality and mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Souza e Souza, Kauê Francisco Corrêa, Moraes, Bianca Portugal Tavares, Paixão, Izabel Christina Nunes de Palmer, Burth, Patrícia, Silva, Adriana Ribeiro, Gonçalves-de-Albuquerque, Cassiano Felippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085498/
https://www.ncbi.nlm.nih.gov/pubmed/33935717
http://dx.doi.org/10.3389/fphar.2021.624704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085498/
https://www.ncbi.nlm.nih.gov/pubmed/33935717
http://dx.doi.org/10.3389/fphar.2021.624704

Ejemplares similares